Characterization of 64Cu-DOTA-conatumumab: a PET tracer for in vivo imaging of death receptor 5
Characterization of 64Cu-DOTA-conatumumab: a PET tracer for in vivo imaging of death receptor 5
About this item
Full title
Author / Creator
Publisher
United States
Journal title
Language
English
Formats
Publication information
Publisher
United States
Subjects
More information
Scope and Contents
Contents
Conatumumab is a fully human monoclonal antibody that binds to and activates human death receptor 5 (DR5; also known as TRAIL receptor 2). The purpose of this study was to characterize (64)Cu-labeled conatumumab as a PET tracer for imaging DR5 in tumors.
DOTA-conatumumab was synthesized by incubating conatumumab with 2,2',2″-(10-(2-(2,5-dioxopyr...
Alternative Titles
Full title
Characterization of 64Cu-DOTA-conatumumab: a PET tracer for in vivo imaging of death receptor 5
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_904475695
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_904475695
Other Identifiers
ISSN
0161-5505
E-ISSN
1535-5667
DOI
10.2967/jnumed.110.086157
